A Study of Anti-VEGFR-3 Monoclonal Antibody IMC-3C5 in Subjects With Advanced Solid Tumors

NCT01288989 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
44
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Eli Lilly and Company